the current research on momelotinib for myelofibrosis
Published 8 years ago • 381 plays • Length 2:07Download video MP4
Download video MP3
Similar videos
-
2:07
analysis of long-term exposure to momelotinib in the phase iii simplfy myelofibrosis trials
-
1:53
recent updates from the momentum trial and the value of momelotinib for the treatment of mf
-
4:25
update on momelotinib for myelofibrosis
-
1:26
updates on the use of momelotinib for the treatment of mf & clinical trials evaluating this agent
-
1:13
the current bsh guidelines for the diagnosis and evaluation of prognosis of myelofibrosis
-
1:16
indirect comparison of the safety of momelotinib vs fedratinib in patients with myelofibrosis
-
3:03
an insight into the momentum trial: safety and efficacy of momelotinib for the treatment of mf
-
1:28
momelotinib in 2024: how should this agent be used in mf with anemia?
-
10:47
new research confirms groundbreaking science behind nes infoceuticals
-
7:59
50 years of ebmt | per ljungman — ebmt's roles & strategies in virus and pandemic management
-
3:43
momelotinib: a promising drug for patients with myelofibrosis
-
2:20
quantifying the anemia benefit of momelotinib in mf: analysis of data from simplify-1 & simplify-2
-
2:26
assessing the impact of momelotinib on transfusion burden in mf: analysis of simplify-1 & momentum
-
2:20
momentum & the potential impact of approval of momelotinib in myelofibrosis
-
2:53
long-term safety of momelotinib in myelofibrosis: pooled data from three phase iii randomized trials
-
1:44
momelotinib: a promising agent in mf
-
2:05
new therapies for mpns
-
2:12
the current challenges and unmet needs in myelofibrosis: clinical practice and trials
-
2:16
current and future treatment approaches for hr-mds
-
1:06
origins and treatment options for anemia in myelofibrosis
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
4:48
an insight into the management of cytopenias in mf